Mayflower Financial Advisors LLC Has $950,000 Stock Position in CVS Health Co. (NYSE:CVS)

Mayflower Financial Advisors LLC lessened its holdings in CVS Health Co. (NYSE:CVSFree Report) by 3.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,036 shares of the pharmacy operator’s stock after selling 415 shares during the quarter. Mayflower Financial Advisors LLC’s holdings in CVS Health were worth $950,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in CVS. Cantor Fitzgerald Investment Advisor L.P increased its position in shares of CVS Health by 92.9% during the 1st quarter. Cantor Fitzgerald Investment Advisor L.P now owns 377,875 shares of the pharmacy operator’s stock worth $38,245,000 after purchasing an additional 181,966 shares during the last quarter. United Bank raised its holdings in shares of CVS Health by 7.2% in the 1st quarter. United Bank now owns 18,658 shares of the pharmacy operator’s stock valued at $1,888,000 after purchasing an additional 1,260 shares during the period. Loomis Sayles & Co. L P grew its holdings in CVS Health by 4,063.8% during the first quarter. Loomis Sayles & Co. L P now owns 12,075 shares of the pharmacy operator’s stock worth $1,222,000 after purchasing an additional 11,785 shares during the period. Zions Bancorporation N.A. increased its holdings in shares of CVS Health by 116.9% during the 1st quarter. Zions Bancorporation N.A. now owns 2,572 shares of the pharmacy operator’s stock worth $260,000 after acquiring an additional 1,386 shares during the last quarter. Finally, Ergoteles LLC bought a new position in CVS Health during the first quarter worth $1,551,000. Institutional investors own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently commented on CVS. Royal Bank of Canada decreased their target price on CVS Health from $86.00 to $84.00 and set an “outperform” rating on the stock in a research report on Thursday, February 8th. TD Cowen dropped their target price on CVS Health from $102.00 to $99.00 and set an “outperform” rating for the company in a report on Monday, December 11th. Piper Sandler raised their target price on shares of CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Friday, March 15th. Barclays initiated coverage on shares of CVS Health in a research report on Wednesday, March 6th. They issued an “equal weight” rating and a $78.00 price target for the company. Finally, SVB Leerink initiated coverage on CVS Health in a research report on Monday, February 26th. They set an “outperform” rating and a $88.00 price target on the stock. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $89.44.

Check Out Our Latest Report on CVS Health

Insider Activity at CVS Health

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the sale, the executive vice president now directly owns 39,765 shares in the company, valued at approximately $3,059,916.75. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.25% of the stock is currently owned by company insiders.

CVS Health Price Performance

Shares of NYSE:CVS opened at $79.76 on Monday. The firm has a 50 day simple moving average of $75.91 and a 200 day simple moving average of $73.61. The company has a market cap of $100.37 billion, a price-to-earnings ratio of 12.35, a PEG ratio of 1.05 and a beta of 0.52. CVS Health Co. has a one year low of $64.41 and a one year high of $83.25. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.86 and a quick ratio of 0.63.

CVS Health (NYSE:CVSGet Free Report) last posted its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, beating the consensus estimate of $2.01 by $0.11. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The firm had revenue of $93.81 billion during the quarter, compared to the consensus estimate of $90.58 billion. During the same period last year, the company earned $1.99 earnings per share. The business’s quarterly revenue was up 11.9% on a year-over-year basis. Research analysts predict that CVS Health Co. will post 8.33 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be given a $0.665 dividend. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.34%. CVS Health’s dividend payout ratio (DPR) is presently 41.18%.

CVS Health Profile

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Read More

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSFree Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.